Status:
RECRUITING
The Role of Pharmaco-mechanical Thrombectomy in Management of Acute Lower Extremity Arterial Ischemia
Lead Sponsor:
Assiut University
Conditions:
Acute Limb Ischemia
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The goal of our protocol is to re-establish patency in ALLI, by combining both balloon maceration of a thrombus and angiojet PMT thus decreasing complications associated with prolonged periods of thro...
Detailed Description
Acute lower extremity arterial ischemia (ALLI) is a common emergency in vascular surgery that has a high risk of limb amputation and mortality .It is caused by the blockage of an arterial flow to an e...
Eligibility Criteria
Inclusion
- Age ≥ 18 years
- Symptom onset within 14 days for acute limb ischemia or within 30 days for subacute limb ischemia due to embolic or thrombotic occlusion of a native arteries, bypass graft, or arterial stent.
- Rutherford category I, IIa or IIb
Exclusion
- ALLI secondary to dissections, vasculitis, and/or target vessel trauma
- Pregnancy or positive pregnancy test
- Rutherford category III Irreversible (neglected) limb ischemia
- patients allergic to contrast agent,
- serum creatine\>300 mmol/L
Key Trial Info
Start Date :
January 20 2024
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 20 2025
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT06222658
Start Date
January 20 2024
End Date
December 20 2025
Last Update
January 25 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Asyut University Hospital
Asyut, Egypt